David M Loeb Selected Research

Samarium-153

7/2011	A treatment planning method for sequentially combining radiopharmaceutical therapy and external radiation therapy.
12/2010	Tandem dosing of samarium-153 ethylenediamine tetramethylene phosphoric acid with stem cell support for patients with high-risk osteosarcoma.
6/2009	Dose-finding study of 153Sm-EDTMP in patients with poor-prognosis osteosarcoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David M Loeb Research Topics

Disease

34	Neoplasms (Cancer) 08/2021 - 08/2002
12	Sarcoma (Soft Tissue Sarcoma) 01/2020 - 12/2011
10	Osteosarcoma (Osteogenic Sarcoma) 01/2020 - 01/2009
9	Ewing Sarcoma (Sarcoma, Ewing) 01/2021 - 11/2010
7	Neoplasm Metastasis (Metastasis) 10/2020 - 10/2015
5	Hematologic Neoplasms (Hematological Malignancy) 12/2016 - 06/2013
4	Leukemia 12/2016 - 12/2009
3	Residual Neoplasm 01/2021 - 07/2014
3	Chordoma 01/2017 - 10/2011
3	Aplastic Anemia (Anemia, Hypoplastic) 11/2016 - 12/2007
2	Wilms Tumor (Wilm's Tumor) 10/2018 - 12/2016
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2018 - 08/2002
2	Pain (Aches) 12/2016 - 06/2013
2	Hypoxia (Hypoxemia) 01/2015 - 12/2011
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 07/2014 - 07/2014
2	Disease Progression 07/2014 - 01/2013
2	Infections 11/2009 - 04/2008
1	Rhabdoid Tumor (Rhabdoid Tumors) 10/2022
1	Neuroblastoma 08/2021
1	Peripheral Nervous System Diseases (PNS Diseases) 02/2020
1	Peripheral Nervous System Neoplasms 01/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020
1	Rhabdomyosarcoma 02/2018
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2018
1	Alveolar Rhabdomyosarcoma 10/2017
1	Circulating Neoplastic Cells 10/2017
1	Embolism (Embolus) 10/2017
1	Hypertension (High Blood Pressure) 10/2017
1	Hemorrhage 10/2017
1	Thrombosis (Thrombus) 10/2017
1	Proteinuria 10/2017
1	Wounds and Injuries (Trauma) 10/2017
1	Solitary Fibrous Tumors 01/2017
1	Chondrosarcoma 01/2017
1	Alveolar Soft Part Sarcoma 01/2017
1	Hypersensitivity (Allergy) 12/2016

Drug/Important Bio-Agent (IBA)

6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2017 - 05/2003
4	Proteins (Proteins, Gene)FDA Link 08/2021 - 06/2006
4	Pharmaceutical PreparationsIBA 01/2020 - 01/2013
4	Transcription Factors (Transcription Factor)IBA 01/2015 - 12/2009
4	Small Interfering RNA (siRNA)IBA 01/2015 - 10/2011
3	EWS-FLI fusion proteinIBA 01/2021 - 11/2010
3	Biological ProductsIBA 01/2020 - 02/2012
3	Dasatinib (BMS 354825)FDA Link 01/2018 - 03/2016
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2017 - 12/2011
3	phosphonic acidIBA 06/2013 - 06/2009
3	samarium Sm-153 lexidronam (Quadramet)FDA Link 06/2013 - 06/2009
3	Samarium-153IBA 07/2011 - 06/2009
2	Bortezomib (Velcade)FDA Link 08/2021 - 06/2013
2	RNA (Ribonucleic Acid)IBA 01/2021 - 10/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 10/2016
2	Cisplatin (Platino)FDA LinkGeneric 02/2020 - 10/2017
2	PlatinumIBA 02/2020 - 04/2005
2	Antineoplastic Agents (Antineoplastics)IBA 02/2020 - 03/2011
2	Docetaxel (Taxotere)FDA Link 01/2020 - 06/2013
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2018 - 01/2015
2	Bevacizumab (Avastin)FDA Link 10/2017 - 05/2014
2	Monoclonal AntibodiesIBA 10/2017 - 04/2016
2	AntigensIBA 12/2016 - 01/2015
2	WT1 ProteinsIBA 12/2016 - 12/2011
1	pembrolizumabIBA 10/2022
1	Proteasome InhibitorsIBA 08/2021
1	selinexorIBA 08/2021
1	Proteasome Endopeptidase Complex (Proteasome)IBA 08/2021
1	Carrier Proteins (Binding Protein)IBA 08/2021
1	Nucleic AcidsIBA 01/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	plerixafor FDA Link 01/2021
1	S-Phase Kinase-Associated Proteins (Skp1 Protein)IBA 10/2020
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2020
1	Carboplatin (JM8)FDA LinkGeneric 02/2020
1	Gemcitabine FDA Link 01/2020
1	Cysteine (L-Cysteine)FDA Link 01/2020
1	saracatinibIBA 01/2020
1	taxaneIBA 01/2020
1	130-nm albumin-bound paclitaxelIBA 01/2020
1	Sunitinib (Sutent)FDA Link 01/2018
1	Imatinib Mesylate (Gleevec)FDA Link 01/2018
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2018
1	IronIBA 01/2018
1	temsirolimus FDA Link 01/2018
1	liposomal doxorubicin (Doxil)FDA Link 01/2018
1	SulfurIBA 01/2018
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2018
1	regorafenibIBA 01/2018
1	LGK974IBA 10/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2017
1	Methotrexate (Mexate)FDA LinkGeneric 10/2017
1	Peptides (Polypeptides)IBA 12/2016

Therapy/Procedure

24	Therapeutics 10/2022 - 08/2002
18	Drug Therapy (Chemotherapy) 10/2020 - 08/2002
6	Transplantation 12/2016 - 01/2009
4	Hematopoietic Stem Cell Transplantation 10/2018 - 03/2011
4	Surgical Amputation (Amputations) 10/2017 - 01/2009
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 12/2017 - 01/2016
2	Radiotherapy 06/2013 - 06/2009
2	Immunotherapy 01/2009 - 05/2007
1	Bioreactors (Bioreactor) 11/2018
1	Precision Medicine 01/2017
1	Off-Label Use 01/2017